PATENT CLAIM ANALYSIS

Application Number: 16124781
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "021100"]

Abstract:
The present invention relates to a sterile solution comprising: octreotide in the form of a pharmaceutically acceptable salt, present at a concentration equivalent to 2.0 mg/ml to 2.5 mg/ml of octreotide base, and at least one preservative in a pharmaceutically acceptable vehicle, wherein the sterile solution is present in an injection device.

Claim (Index 3):
The sterile solution according to  claim 1 , wherein the concentration of octreotide base is 2.5 mg/ml.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.54054
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12171999', '13098138', '12490979', '15597523', '14172384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7339346468023674
- 35 USC 102 Novelty (BERT): 0.4794674412218268
- Combined Prediction Score: 0.7084879262443133
- Mean Citation Score: 172.25295599999995
- Max Citation Score: 177.55553
- Similarity Product: 138.9793281793928

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test